1 Levkovitz Yechiel, MD

UPDATE: 01/09/12

CURRICULUM VITAE

NAME Yechiel Levkovitz MD, M.H.A 056126295

(First) (Last) Academic Degree ID No.

FACULTY/DEPT Director, Day-Hospital and Director of Cognitive and Emotional Lab Shalvata Mental Health Center

Head of Continuing Medical Education (CME) , School of Medicine, Tel- Aviv University.

HOSPITAL/DEPT Shalvata Mental Health Center, Hod-Hasharon 972-9-7478568 Tel. No.

HOME ADDRESS 12 Haim Herzog st., 972-3-6354371 Tel. No.

E-MAIL: [email protected]

DATE AND PLACE 20-01-1960,

OF BIRTH (date, country)

ZAHAL (ISRAELI) Chief of Battalion

MILITARY SERVICE 1978 - 1982 (Enlisted Discharged)

MARITAL STATUS Married + 2

NO. OF CHILDREN (status children)

A. EDUCATION

PERIOD OF STUDY Technion Institute, , Israel

(DATES) (Name of University, City, Country) Medical Degree 1982-1989 (Subject) MD, cum laude 2 Levkovitz Yechiel, MD

(Degree or Professional License) 1989 (Date Awarded) 3 Levkovitz Yechiel, MD

Title of Doctoral The role of TNF in inflammatory disease Dissertation (Title)

Name of Dr. Reuven Porat Supervisor

B. FURTHER STUDIES

Period of Study 1992-1997 (dates) University Name of University, City/country (if not Israel)

Psychotherapy Program Subject

1990-1995

Tel Aviv University Name of University, City/country (if not Israel)

Postgraduate Courses in Psychiatry Subject

C. ACADEMIC AND PROFESSIONAL EXPERIENCE (FOR MDs – ACADEMIC EXPERIENCE; CLINICAL EXPERIENCE)

ACADEMIC EXPERIENCE

Period (Dates) Weizmann Institute, , Israel 1991 - 1999 (Name of University/Institution, City, Country)

Neurobiology (Subject)

Neurobiology Department

Visiting scientist, Research fellow Rank/Function 4 Levkovitz Yechiel, MD

Period (Dates) Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel 1994 - 1998 (Name of University/Institution, City, Country)

Psychiatry Department

Instructor___ Rank/Function

Period (Dates) Johns Hopkins School of Medicine, Baltimore, U.S.A. 1999 - 2001 (Name of University/Institution, City, Country)

Neuroscience Department

Post-Doctoral Fellow Rank/Function

Period (Dates) Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel 2.5.2009 - (Name of University/Institution, City, Country) present Psychiatry Department

Associate Professor Rank/Function Period (Dates) BeN Gurion University of the Negev 2009 - 2012 (Name of University/Institution, City, Country)

Health Systems Management Department

M.H.A Rank/Function

CLINICAL EXPERIENCE

Period (Dates) Ichilov Medical Center, Tel Aviv, Israel 1989 - 1990 (Name of University/Institution, City, Country)

Medical doctor Rank/Function

Period (Dates) Shalvata Mental Health Center, Hod-Hasharon, Israel 1991 - 1995 (Name of University/Institution, City, Country)

Psychiatry Department 5 Levkovitz Yechiel, MD

Resident __ Rank/Function

6 Levkovitz Yechiel, MD

Period (Dates) Shalvata Mental Health Center, Hod-Hasharon, Israel 1995 - 1999 (Name of University/Institution, City, Country)

Psychiatry Department

Deputy Director Inward Department, Director Affective Disorder Unit __ Rank/Function

Period (Dates) Shalvata Mental Health Center, Hod-Hasharon, Israel 1998 - 1999 (Name of University/Institution, City, Country) (7 months) Psychiatry Department

Acting Director, Inward Department Rank/Function

Period (Dates) Shalvata Mental Health Center, Hod-Hasharon, Israel 2001 - present (Name of University/Institution, City, Country)

Psychiatry Department

Director of Day-Hospital Rank/Function

Period (Dates) Brainsway Ltd., , Israel 2003 - present (Name of University/Institution, City, Country)

Medical consultant Rank/Function

E. ACADEMIC AND PROFESSIONAL AWARDS (Prizes, fellowships, grants, scholarships, etc.)

E 1. Grants and Prizes

Year Title, Name of Institution, City, Country, Occasion 1998 Edward Kass Award for Medical Research given by the American Physicians Fellowship Association 1998 Research Grant from The National Institute for Psychobiology in Israel (P.I. 28,000 NIS) 1999 American College of Neuropsychopharmacology (ACNP) Travel Award 2001 Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) (P.I. $30,000) 2002 Woodcraft Investigator for 2001 given by the National Alliance for Research on Schizophrenia and Depression (NARSAD) 7 Levkovitz Yechiel, MD

2002 Research Grant from the National Institute for Psychobiology in Israel (P.I. 30,000 NIS) 2003 Stanley Foundation Research Institute, Treatment Trial Grant ( Co- PI with Dr. S. Mendlovic, $300,000) 2003 Award of "High Quality Project" - Shalvata Mental Health Center, Hod- Hasharon, Israel 2004 Israel Society for Biological Psychiatry Award for Basic Science Research in Psychiatry (5,000 NIS) 2004 The Gonda (Goldschmied) Foundation Grant (with Dr. Goldstein, Bar Ilan, Electrophysiological Indicators of Cognitive Function and Response to Treatment in Major Depressive Disorder) (Co-PI with Dr. Avi Goldstein , 15,000 NIS) 2004 Israel Society for Biological Psychiatry Award for Basic Research in Psychiatry (with Dr. Simon Shamay, supervisor) (5,000 NIS) 2005 The Gonda (Goldschmied) Foundation Grant (with Dr. Goldstein, Bar Ilan, Electrophysiological Indicators of Inhibitory Function in Schizophrenia) (C0-PI with Dr. Avi Goldstein , 15,000 NIS) 2006 Research Grant from the Adam Super Center for Brain Research, Tel Aviv University (PI , $5,000) 2006 Research Grant from the Israel Science Foundation (ISF Co-PI), Schizophrenia and TMS-Induced Abnormal Language Lateralization: Inhibition and Facilitative Processes. (Secondary investigator , P.I. Prof. Michal Lavidor , $300,000) 2009 Secretary of the committee for novel technologies in psychiatry) Israel). 2010 Member of the World Psychiatry Association (WPA) Section of Pharmacopsychiatry. 2011 Research Grant from the Israel Association for Drug Addiction Cognitive Profile of Patient suffer from Schizophrenia and use Cannabis. (NIS35,500)

E 1. Conferences

Year Title, Name of Institution, City, Country, Occasion

1997 Chairman, Israel Psychiatric Association, Symposium on Signal Transduction 2007 Co-Chairman: The Batsheva de Rothschild Interdisciplinary Workshop on Transcranial Magnetic Stimulation (TMS) 2007 Chair of Symposia in the 62th annual conference of the American society of biological psychiatry. (Novel application for transcranial magnetic stimulation). 2008 Chairman Israel Society of Biological Psychiatry 2008 Member of World Federation of Biological Psychiatry Task Force on Brain Stimulation

2009 Chair of the 1st Interactive Conference for Residencies in Psychiatry 8 Levkovitz Yechiel, MD

2009 Member of the scientific committee of the 13th Conference of the Israel Society of Psychiatry 2009 Chair of Symposia in the 64th annual conference of the American Society of biological psychiatry. (Minocycline in early phase schizophrenia: from the lab to the clinic). 2009 Chair of Symposia in the 5th meeting of the Israel conference for treating mental disorders (The approach to patients suffer from metabolic syndrome and schizophrenia ). 2009 Member of Task Force on BRAIN STIMULATION, World Federation of Societies of Biological Psychiatry. 2010 Member of the Membership Committee, World Federation of Societies of Biological Psychiatry. 2009 Member of the international committee of the World Conference of Societies of Biological Psychiatry. 2010 Invited Speaker, Psychiatry Department, McLean, Harvard School of Medicine. 2010 Invited Speaker, Neurology and Cognitive Neurology Department Beth Israel, Harvard School of Medicine. 2010 Invited Speaker, Grand Round, Psychiatry Department, Tauft, Harvard School of Medicine. 2010 Invited Speaker, Psychiatry Department, DRCP, MGH, Harvard School of Medicine. 2010 Invited Speaker, France Association for Biological Psychiatry and Neuropsychopharmachology, Lyon, France. 2010 Members of the International Scientific Committee of the 4th Mediterranean Congress of the WFSBP in Thessaloniki, (18-21 November 2010) 2011 Memember of the European College of Neuropsychopharmacology (ECNP) Membership Committee 2012 Invited Speaker, Psychiatry Department, Mount Sianai, School of Medicine. F. MEMBERSHIP IN PROFESSIONAL SOCIETIES

Year Society (Country) 1997-1999 The New York Academy of Sciences, U.S.A.

1995-2003 Israel society for Neurosciences, Israel

1993-2003 Israel Psychiatric Association, Israel

2001-2003 International Society for Affective Disorders, International

2003-2006 Elected Treasurer, Israel Society for Anxiety and Affective Disorders, Israel

2006-2011 Elected President, Israel Society for Biological Psychiatry, Israel

9 Levkovitz Yechiel, MD

G1. MSC STUDENTS SUPERVISED BY CANDIDATE

Student’s Title of Thesis Academic Institution Name 1994 N. Kinor Effect of raphe graft Neurobiology transplantation in the Department, Weizmann hippocampus on spatial memory Institution of Science

1995 O. Ophir Effect of 5-HTP on functional Tel Aviv University memory in schizophrenic patients 1996 R. Caftori Comparing SSRI Vs. SNRI on Haifa University memory function in major depression 1996 Y. Barak Perception of Ill- partner and Hebrew University spouse in affective disorders 1997 G. Arnest Effects of Ondansetron , 5-HT-3 Tel-Aviv University antagonist, on memory impairment in schizophrenia 1999 A. Mottes Comparing laboratory, everyday Bar-Ilan University memory function in schizophrenic and depressed patients 2003 N. Hagai Ultimatum bargaining behavior of Tel-Aviv University people affected by schizophrenia 2003 Y. Cohen Cognitive and emotional Tel-Aviv University impairment in OCD patients 2005 R. Itzhak ADHD in adults: diagnosis and Bar-Ilan University laboratory tests in assessment outcome measures

G2. THESIS FOR PhD AND DOCTOR IN MEDICINE SUPERVISED BY CANDIDATE Year Name of Title of Thesis Name of Hospital Student

1994 H. Harari Effect of 5-HT3 antagonist, Ondansetron, on Shalvata Mental M.D. functional memory in schizophrenic patients Health Center 1995 Y. Bloch The effects of activating the cholinergic, the Tel-Aviv University M.D. serotoninergic or both, on the cognitive sideeffects caused by electroconvulsive therapy

1998 N. Levi Perception of dyadic relationship and mutual Tel-Aviv University M.D. support after acute MI 2004 G. Aizenberg Latent inhibition in schizophrenia and bipolar Shalvata Mental M.D. patients Health Center 2004 Y. Barnea Novel latent inhibition for chronic schizophrenia Tel-Aviv University M.D. 2005 Y. Beitelman The role of the early gene response (Egr) and c- Shalvata Mental M.D. Jun in affective disorder Health Center 2006 A. Gadot The effect of KARATE on the well being of M.D. psychiatric patients 10 Levkovitz Yechiel, MD

2006 M. Ballas Functional neuroanatomy of ‘self-consciousness’ Tel-Aviv University PhD student as revealed by combination of deep transcranial magnetic stimulation (dTMS) and functional magnetic resonance imaging (fMRI) 2006 E. Harel Deep transcranial magnetic stimulation - a Shalvata Mental M.D. physical and psychological study clinical Health Center neurophysiology 2006 A. Seker The patients and therapist emotional and Shalvata Mental M.D. cognitive reaction when expose to medical Health Center records 2007 L. Rabani Cognitive and negative impairment in Tel-Aviv University PhD student schizophrenia

2007 S. Lev-Ran Transcranial magnetic stimulation of the Shalvata Mental M.D. ventromedial frontal cortex impairs affective Health Center theory of mind processing 2009 R. Itzhak Antidepressants induce cellular insulin resistance Tel-Aviv University PhD student by activation of IRS-1 kinases.

2009 H. Gvirtz Empathy as an endophenotype in borderline Tel-Aviv University Msc. Student personality disorder

2009 K. Yefet Electrophysiological correlate of negative Tel-Aviv University PhD student symptoms in schizophrenia

2008 M.Fischer Oxytocin for empathy in schizophrenia Haifa University PhD student

2010 H. Gvirtz Empathy in borderline personality disorder Tel-Aviv University Phd student

11 Levkovitz Yechiel, MD

LIST OF SCIENTIFIC PUBLICATIONS

B.1. ORIGINAL ARTICLES

B.1. Articles Published

1. Levkovitz Y, Weiser M, Levy A. Involuntary outpatient commitment: ethics and problems. Med Law 1993; 12: 213-220.

2. Levkovitz Y, Richter-Levin G, Segal M. Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats. Neurobiol Aging 1994; 15: 635-641. (NEUROSCIENCES Rank 21/200, IF 5.59)

3. Levkovitz Y, Segal M. Acetylcholine mediates the effects of fenfluramine on dentate granule cell excitability in the rat. Eur J Pharmacol 1994; 264: 279-284. (Pharmachology Rank 72/199, IF 2.55)

4. Weiser M, Levkovitz Y, Neuman M, Yehuda S. Decrease in serum iron in acutely psychotic schizophrenic patients. Int J Neurosci 1994; 78: 49-52. (NEUROSCIENCES Rank 178/200, IF 0.83)

5. Levkovitz Y, Keisar N, Kronenberg Y, Hagai H, Gaoni B. Clozapine for schizophrenia. J Am Acad Child Adolesc Psychiatry 1994; 33: 431. (PSYCHIATRY Rank 9/94, IF 4.767)

6. Levkovitz Y, Kronenberg Y, Gaoni B. Can clozapine trigger OCD? J Am Acad Child Adolesc Psychiatry 1995; 34: 263. (PSYCHIATRY Rank 9/94, IF 4.767)

7. Levkovitz Y, Kronenberg Y, Keisar N, Zvygaleski M, Gaoni B, Gadoth N. Clozapine for tardive dyskinesia in adolescents. Brain Dev 1995; 17: 213-215. (IF 1.598)

8. Levkovitz Y, Greenberger V, Segal M. The effects of raphe grafts on hippocampal electrophysiology in aged rats. Brain Res 1996; 719: 234-238. (NEUROSCIENCES Rank 107/200, IF 2.34)

9. Levkovitz Y, Segal M. Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation. J Neurosci 1997; 17: 5591-5598. (NEUROSCIENCES Rank 15/200, IF 7.453)

10. Levkovitz Y, Segal M. Age-dependent local modulation of hippocampal-evoked responses to 12 Levkovitz Yechiel, MD

perforant path stimulation. Neurobiol Aging 1998; 19: 317-324. (NEUROSCIENCES Rank 21/200, IF 5.599)

11. Levkovitz Y, Marx J, Grisaru N, Segal M. Long-term effects of transcranial magnetic stimulation on hippocampal reactivity to afferent stimulation. J Neurosci 1999; 19: 3198-3203. (NEUROSCIENCES Rank 15/200, IF 7.453)

12. Levkovitz Y, Avingone E, Groner Y, Segal M. Upregulation of GABA neurotransmission suppresses hippocampal excitability and prevents long-term potentiation in transgenic superoxide dismutase-overexpressing mice. J Neurosci 1999; 19: 10977-10984. (NEUROSCIENCES Rank 15/200, IF 7.453)

13. Treves I, Fennig S, Levkovitz Y, Elizur A. Couple dynamics of bipolar patients: “The switch process”. Family Therapy 1999; 26: 191-199.

14. Treves I, S. Fennig, S. Fennig, Kastner M, Y. Levkovitz. Whom would you like to treat? Therapists' preferred gender of therapist and patient. Am J Psychoteraphy (Accepted).

15. Levkovitz Y, Fennig S, Horesh N, Barak V, Treves I. Perception of ill spouse and dyadic relationship in couples with affective disorder and those without. J Affect Disord 2000; 58: 237-240. (PSYCHIATRY Rank 24/94, IF 3.138)

16. O'Donovan KJ, Levkovitz Y, Ahn D, Baraban JM. Functional comparison of Egr3 transcription factor isoforms: identification of an activation domain in the N-terminal segment absent from Egr3, a major isoform expressed in brain. J Neurochem 75: 1352-1357, 2000. (NEUROSCIENCES Rank 39/200, IF 4.260)

17. Levkovitz Y, Shahar G, Native G, Hirsfeld E, Treves I, Krieger I, Fennig S. Group interpersonal psychotherapy for patients with major depressive disorder - pilot study. J Affect Disord 2000; 60: 191-195. (PSYCHIATRY Rank 24/94, IF 3.138)

18. Levkovitz Y, O'Donovan KJ, Baraban JM. Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors. J Neurosci 2001; 21: 45-52. (NEUROSCIENCES Rank 15/200, IF 7.453)

19. Levkovitz Y, Segal M. Aging affects transcranial magnetic modulation of hippocampal evoked potentials. Neurobiol Aging 2001; 22: 255-263. (NEUROSCIENCES Rank 21/200, IF 5.599)

20. Y. Levkovitz, Bloch Y, Diskin A, Kaplan D, Abramovitch I. 13 Levkovitz Yechiel, MD

Fluvoxamine for psychosis in Alzheimer’s disease. J Nerv Ment Dis 2001; 189: 126-129. (PSYCHIATRY Rank 51/94, IF 1.957)

21. Y. Levkovitz, Grisaru N, Segal M. Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmachology 2001; 24: 608-616. (NEUROSCIENCES Rank 19/200, IF 5.889)

22. Levkovitz Y, Baraban JM. A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation. J Neurosci 2001; 21: 5893-5901. (NEUROSCIENCES Rank 15/200, IF 7.453)

23. Bloch Y, Levkovitz Y, Bloch AM, Mendlovic S, Ratzoni G. Electroconvulsive therapy in adolescents: similarities to and differences from adults. J Am Acad Child Adolesc Psychiatry 2001; 40: 1332-1336. (PSYCHIATRY Rank 9/94, IF 4.767)

24. Levkovitz Y, Baraban JM. A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J Neurosci 2002; 22: 3845-3854. (NEUROSCIENCES Rank 15/200, IF 7.453)

25. Levkovitz Y, Caftori R, Avital A, Richter-Levin G. The SSRI drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Res Bull 2002; 58: 345-350. (NEUROSCIENCES Rank 139/200, IF 1.684)

26. Fennig S, Mottes A, Ricter-Levin G, Treves I, Levkovitz Y. Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression. J Nerv Ment Dis 2002; 190: 677-682. (PSYCHIATRY Rank 51/94, IF 1.957)

27. Levkovitz Y, Lamy D, Ternochiano P, Treves I, Fennig S. Perception of dyadic relationship and emotional states in patients with affective disorder. J Affect Disord 2003; 75: 19-28. (PSYCHIATRY Rank 24/94, IF 3.138)

28. Levkovitz Y, Ophir-Shaham O, Bloch Y, I Treves I, Fennig S, Grauer E. Effect of L-tryptophan on memory in patients with schizophrenia. J Nerv Ment Dis 2003; 191: 568-573. (PSYCHIATRY Rank 51/94, IF 1.957)

29. Gil-Ad I, Shtaif B, Levkovitz Y, Dayag M, Zeldich E, Weizman A. Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. J Mol Neurosci 2004; 22: 189-198. (NEUROSCIENCES Rank 71/200, IF 2.96)

14 Levkovitz Yechiel, MD

30. Bloch Y, Levkovitz Y, Atshuler A, Dvoretzki V, Fennig S, Ratzoni G. Use of topical application of lidocaine-prilocaine cream to reduce injection- site pain of depot antipsychotics. Psychiatr Serv 2004; 55: 940-941. (PSYCHIATRY Rank 41/94, IF 2.43)

31. Fennig S, Secker A, Levkovitz Y, Barak V, Benyakar M, Farina J, Roe D, Treves I, Fennig S. Are psychotherapists consistent in their ethical attitude to patient confidentiality? Isr J Psychiatry Relat Sci 2004; 41: 82-89.

32. Bloch Y, Ratzoni G, Sobol D, Mendlovic S, Gal G, Levkovitz Y. Gender differences in electroconvulsive therapy: a retrospective chart review. J Affect Disord 2005; 84: 99-102. (PSYCHIATRY Rank 24/94, IF 3.138)

33. Levkovitz Y, Arnest G, Mendlovic S, Treves I, Fennig S. The effect of Ondansetron on memory in schizophrenic patients. Brain Res Bull 2005; 65: 291-295. (NEUROSCIENCES Rank 139/200, IF 1.684)

34. Gal G, Mendlovic S, Bloch Y, Beitler G, Levkovitz Y, Young AM, Feldon J, Ratzoni G. Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients. Behav Brain Res 2005; 159: 267-275. (NEUROSCIENCES Rank 95/200, IF 2.591)

35. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A . Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 2005; 27: 29-42. (NEUROSCIENCES Rank 71/200, IF 2.96)

36. Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, Weizman A. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 2006; 15: 107-112. (ONCOLOGY Rank 103/127, IF 1.567)

37. Fennig S, Secker A, Treves I, Ben Yakar M, Farina J, Roe D, Levkovitz Y, Fennig S. Ethical dilemmas in psychotherapy: comparison between patients, therapists and laypersons. Isr J Psychiatry Relat Sci 2005; 42: 251-257.

38. Shamay-Tsoory SG, Shur S, Barcai-Goodman L, Mendlovic S, Harari H, Levkovitz Y. Dissociation of cognitive from affective components of theory of mind in schizophrenia. Psychiatry Res 2007; 149: 11-23. (PSYCHIATRY Rank 46/94, IF 2.31)

15 Levkovitz Yechiel, MD

39. Segal-Trivitz Y, Bloch Y, Goldburt Y, Sobol-Havia D, Levkovitz Y, Ratzoni G. Comparison of symptoms and treatments of adults and adolescents with borderline personality disorder. Int J Adolesc Med Health 2006; 18: 215-220. (Not cited).

40. Shamay-Tsoory SG, Aharon-Peretz J, Levkovitz Y. The neuroanatomical basis of affective mentalizing in schizophrenia: comparison of patients with schizophrenia and patients with localized prefrontal lesions. Schizophr Res 2007; 90: 274-283. (PSYCHIATRY Rank 14/94, IF 4.26)

41. Roth Y, Amir A, Levkovitz Y, Zangen A. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 2007; 24: 31-38. (PSYCHIATRY Rank 14/94, IF 4.26)

42. Levkovitz Y, Levi U, Braw Y, Cohen H. Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia. Brain Res 2007; 1154: 154-162. (NEUROSCIENCES Rank 107/200, IF 2.34)

43. Shamay-Tsoory SG, Shur S, Harari H, Levkovitz Y. Neurocognitive basis of impaired empathy in schizophrenia. Neuropsychology 2007; 21: 431-438. (PSYCHOLOGY Rank 11/60, IF 3.12)

44. Levkovitz Y, Ben-Shushan G, Hershkovitz A, Isaac R, Gil-Ad I, Shvartsman D, Ronen D, Weizman A, Zick Y. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci 2007; 36: 305-312. (NEUROSCIENCES Rank 36/200, IF 4.60)

45. Agai N, Kron S, Carmel Z, Mendlovic S, Levkovitz Y. Ultimatum bargaining behavior of people affected by schizophrenia. Psytchiatry Res 2007 Oct 2 (PSYCHIATRY Rank 46/94, IF 2.31)

46. Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol 2007 Oct 29; (NEUROSCIENCES Rank 86/200, IF 2.71)

47. Braw Y, Bloch Y, Mendlovic S, Ratzoni G, Gal G, Tripto A, Levkovitz Y. Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophr Bull 2007 Nov 5; (PSYCHIATRY Rank 12/94, IF 4.35)

48. Kalman N, Luria I, Ratzoni G, Levkovitz Y, Braw Y, Linder M, Bloch Y. Electroconvulsive therapy in adolescents: Patient attitudes, satisfaction and informed consent procedures. Int J Child Adolesc Health 2008;1(3):00-00

49. Bloch Y, Sobol D, Levkovitz Y, Kron S, Ratzoni G. Reasons for referral to electroconvulsive therapy: adolescents versus adults. 16 Levkovitz Yechiel, MD

Australasian Psychiatry 2008;16 (3):191-194 (PSYCHIATRY Rank 57/94, IF1.90) 50. Bloch Y, Grisaru N, Harel E, Beitler G, Faibel N, Ratzoni G, Levkovitz Y. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in the treatment of resistant depression in adolescents: open feasibility study. J ECT 2008;24 (2):156-159 (PSYCHIATRY Rank 74/94, IF 0.866)

51. G. Gal, Y. Barnea, L. Biran, S. Mendlovic, T. Gedi, M. Halavy, J. Feldon, S. Fennig, Y.Levkovitz. Enhancement of Latent Inhibition in Patients with Chronic Schizophrenia. Behavioural Brain Research 2008 . (NEUROSCIENCES Rank 95/200, IF 2.591)

52. Shur S, Shamay-Tsoory SG, Levkovitz Y. Integration of emotional and cognitive aspects of theory of mind in schizophrenia and its relation to prefrontal neurocognitive performance. Cognitive Neuroespsychiatry. 2008;13(6):472-90.

53. Shamay-Tsoory SG, Harari H, Szepsenwol O, Lazovsky M, Levkovitz Y. Y. Neuropsychological evidence of impaired cognitive empathy in euthymic bipolar disorder. The Journal of Neuropsychiatry and Clinical Neurosciences ,2009 ;21(1):59-67 (NEUROSCIENCES Rank 126/200, IF 2.00)

54. Braw Y, Bloch Y, Mendlovic S, Ratzoni G, Harari H, Kron, S, Levkovitz Y. Cognitive Profile During Remission: Euthymic Bipolar Disorder Patients Compared to Schizophrenia Patients Clinical Schizophrenia and Related Psychoses, 2007 : 1(3): 243-254. (New Journal)

55. Dominique L, Goshen-Kosover A, Aviani N, Harari H, Levkovitz Y. Implicit memory for spatial context in depression and schizophrenia Journal of Abnormal Psychology ,2008 ;117(4):954-61 (PSYCHIATRY Rank 13/117, IF 5.01)

56. Y. Levkovitz, S. Mendlovich, S. Issaki. Y.Braw, H. Levkovitz-Verbin, G. Gal, S. Fennig, I. Treves, S.Kron. A Double Blind Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia. J. Clinical Psychiatry 2010; 71(2):138-49. (PSYCHIATRY Rank 11/117, IF 5.21)

57. Lexical ambiguity resolution in Wernicke's area and its right homologue. Harpaz Y, Levkovitz Y, Lavidor M. Cortex. 2009 ; 45(9):1097-103. (NEUROSCIENCE Rank 56/231, IF 4.0)

58. Harari H, Shamay-Tsoory SG, Ravid M, Levkovitz Y. Dissociation between cognitive and affective facets of empathy in borderline personality disorder. Psychiatry Res 2010; 28(3); 2779. (PSYCHIATRY Rank 55/117, IF 2.3)

17 Levkovitz Yechiel, MD

59. Fischer M., Shamay-Tsoory SG, Harari H., Levkovitz Y. The effect of intranasal administration of Oxytocin on fear recognition. Neuropsychologia 2010 ; 48(1):179-84. (PSYCHOLOGY Rank 21/71, IF 2.94)

60. Shamay-Tsoory SG, Aharon-Peretz J, Levkovitz Y The role of the orbitofrontal cortex in affective theory of mind deficits in criminal offenders with psychopathic tendencies Cortex 2010 ; 46(5): 668-77. (NEUROSCIENCE Rank 56/231, IF 4.0)

61. Shamay-Tsoory SG, Fischer M, Dvash J, Harari H, Perach-Bloom N, Levkovitz Y.Intranasal Administration of Oxytocin Increases Envy and Schadenfreude (Gloating) Biol Psychiatry. 2009 ; 1;66(9):864-70. (PSYCHIATRY Rank 4/117, IF 8.92)

62. Luria I, Aviram S, Linder M, Kalman N, Ratzoni G, Levkovitz Y, Bloch Y. Understanding and knowledge of psychiatric treatment among adolescents and adults. Clinical Child Psychology and Psychiatry 2009 ;14 :589-94 (not rank) 63. Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. Deep Transcranial Magnetic Stimulation over the Prefrontal Cortex: Evaluation of Antidepressant and Cognitive Effects in Depressive Patients. Brain Stimulation 2009; 46(5); 668-77. (NEUROSCIENCES Rank 41/237, IF 4.96)

64. Bloch Y, Harel AV, Aviram S, Govezensky J, Ratzoni G, Levkovitz Y. Positive Effects of Repetitive Transcranial Magnetic Stimulation on Attention in ADHD Subjects – a Randomized Controlled Pilot Study World Journal of Biological Psychiatry 2010 ;11(5):755-8. (PSYCHIATRY Rank 8/117, IF 5.5)

65. Agay N, Yechiam E., Carmel Z., Levkovitz Y. The non-specific effect of Methylphenidate (Ritalin) on ADHD and healthy adults. Psychopharmacology 2010 ; 210(4):511-9. (PSYCHIATRY Rank 21/117, IF 4.1)

66. Harel EV, Zangen A, Roth Y, Reti Y, Braw Y, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World Journal of Biological Psychiatry 2011; 12:119-26 (PSYCHIATRY Rank 8/117, IF 5.5)

67. Braw Y, Aviram S, Bloch Y, Levkovitz Y. The effect of age on the executive functioning of unmedicated depressed patients. Journal Affective Disorder 2011;129 :342-7 (PSYCHIATRY Rank 8/117, IF 3.7)

68. Isserles M, Rosenberg O, Danon P, Levkovitz Y, Kotler M, Lerer B, Deutsch F, Zangen A. Deep Transcranial Magnetic Stimulation combined with Cognitive Emotional Reactivation for Treatment-Resistant Major Depression. 18 Levkovitz Yechiel, MD

Journal Affective Disorder 2011;128(3):235-42. (PSYCHIATRY Rank 8/117, IF 3.7)

69. Rabany L, Weiser M, Weberloff N, Levkovitz Y. Assessment of Negative Symptoms and Depression in Schizophrenia: Revision of the SANS and How It Relates to the PANSS and CDSS Schizophrenia Research- Revision of SANS and it's relations to PANSS and CDSS . Schizophrenia Research 2011;126:226-30 (PSYCHIATRY Rank 18/117, IF 4.4)

70. Levkovitz Y, Rabany L, Harel EV, Zangen A. Deep Transcranial Magnetic Stimulation Add-on for Treatment of Negative Symptoms and Cognitive Deficits of Schizophrenia: A Feasibility Study. International Journal of Neuropsychopharmacology 2011:28:1-6 (PSYCHIATRY Rank 16/117, IF 4.8)

71. Braw Y, Sela T, Erez G, Sitman R, Bloch Y, Levkovitz Y. Comparison of Comparison of insight among schizophrenia and bipolar disorder patients in remission of affective and positive symptoms: Analysis and critique European Psychiatry (in press) (PSYCHIATRY Rank 39/117, IF 3.08)

72. Lev-Ran S., Shamay-Tsoory SG, Zangen A, Levkovitz Y. Transcranial Magnetic Stimulation of the Ventromedial Prefrontal Cortex Impairs Theory of Mind Learning. European Psychiatry 2012 ;27:285-9 (PSYCHIATRY Rank 39/117, IF 3.08)

73. Levkovitz Y , Sheer A, Harel EV, Katz l, Most D, Zangen A, Isserles M. Differential effects of deep TMS of the prefrontal cortex on apathy and depression Brain Stimulation 2011:4:266-74 (NEUROSCIENCES Rank 41/237, IF 4.96)

74. Rosenberg O, Isserles M, Levkovitz Y, Kotler M, Zangen A, Dannon PN Effectiveness of a second deep TMS in depression: a brief report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011 1;35 :1041-4. (CLINICAL NEUROLOGY Rank 55/167, IF 2.82)

75. Levkovitz Y, Jonathan E. Alpert J, Carrie EB, Mischoulon D, Papakostas GI. Effects of S-adenosylmethionine Augmentation of Serotonin-Reuptake Inhibitor Antidepressants on Cognitive Symptoms of Major Depressive Disorder. European Psychiatry (in press) (PSYCHIATRY Rank 39/117, IF 3.08)

76. Shauli Lev-Ran , Segev A, Braw Y, Levkovitz Y Neurocognitive Functions of Heavy Cannabis using Schizophrenia Patients European Psychiatry 2012 ;27 :365-8 (PSYCHIATRY Rank 39/117, IF 3.08)

77. Bloch Y, Fixman M, Maoz , Mimouni-Bloch A, Levkovitz Y ,Ratzoni G, Aviram S, Gal G. Can computerized cognitive tests assist in the clinical diagnosis of ADHD? 19 Levkovitz Yechiel, MD

The Journal of Neuropsychiatry and Clinical Neurosciences 2012, 1;24(1):111-4 (NEUROSCIENCES Rank 163/237, IF 1.98)

78. Rosenberg O, Isserles M, Levkovitz Y, Kotler M, Zangen A, Dannon PN. Effectiveness of a second deep TMS in depression: a brief report (in press) Prog Neuropsychopharmacol Biol Psychiatry. 2011 ,1;35(4):1041-4. (PSYCHIATRY Rank 43/117, IF 2.877)

79. Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y H-coil Repetitive Transcranial Magnetic Stimulation for Treatment Resistant Major Depressive Disorder: An 18-Week Continuation Safety and Feasibility Study World Journal of Biological Psychiatry 2011; 12:119-26 (PSYCHIATRY Rank 8/117, IF 5.5)

80. Fischer-Shofty M, Levkovitz Y, Shamay-Tsoory SG Oxytocin facilitates accurate perception of competition in men and kinship in women. Social Cognitive and Affective Neuroscience (in press) (NEUROSCIENCES Rank 24/243, IF 6.1)

81. Mayer G, Aviram S, Walter G, Levkovitz Y, Bloch Y. Long term follow-up of adolescents with resistant depression treated with repetitive transcranial magnetic stimulation. Journal of ECT 2012 ;28:84-6. (PSYCHIATRY Rank 81/117, IF 1.2)

82. Rabany L, Weiser M, Weberloff N, Levkovitz Y Guilt and Depression: Two Different Factors in Individuals with Negative Symptoms of Schizophrenia? European Psychiatry (in press) (PSYCHIATRY Rank 39/117, IF 3.08)

83. Gvirts HZ, Harari H, Braw Y, Shefet D, Shamay-Tsoory SG, Levkovitz Y. Executive functioning among patients with Borderline Personality Disorder (BPD) and their relatives Journal Affective Disorder (in press) (PSYCHIATRY Rank 8/117, IF 3.7)

84. Ben-Yehuda A, Aviram S, Govezensky J, Nitzan U, Levkovitz Y, Bloch Y. Suicidal Behavior in Minors - Diagnostic differences between children and adolescents Journal of Developmental and Behavioral Pediatrics (accept) (Developmental Psychology Rank 21/66 , IF 2.2)

85. Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. J Clin Psychiatry. 2012 ;73:728-34 (PSYCHIATRY Rank 11/117, IF 5.21)

20 Levkovitz Yechiel, MD

21 Levkovitz Yechiel, MD

B.2. CASE REPORTS

1. Levkovitz Y, Abramovitch Y, Nizan I. רעילות דילאטין כסיבה אפשרית לדיכאון ראשי / עיקרי. Dilantin toxicity as a possible cause of major depression. Harefuah 124: 762-764, 795, 1993.

2. Weiser M, Levkovitz Y, Shalom S, Neuman M. תגובות רגשיות של צוות פסיכיאטרי לחולים אלימים. Emotional reactions of psychiatric staff to violent patients. Harefuah 1994; 126: 642-645, 691.

3. Levkovitz Y, Kronenberg Y, Keisar N, Harari H, Gaoni B. קלוזאפיין בפרוץ סכיזופרניה של גיל ההתבגרות. Clozapine in adolescence onset schizophrenia. Harefuah 1994; 127: 16-18, 63.

4. Bloch Y, Vardi O, Mendlovic S, Levkovitz Y, Gothelf D, Ratzoni G. Hyperglycemia from olanzapine treatment in adolescents. J Child Adolesc Psychopharmacol 2003; 13: 97-102.

B.3. REVIEW ARTICLES

1. Levkovitz Y, Levy A, Levin Y, Neuman M. מוות פתאומי בחולים פסיכיאטריים. Sudden death in psychiatric patients. Harefuah 1990; 119: 323-326.

2. Bloch Y, Levkovitz Y, Pollack M, Traves I. החלטות לגבי טכניקת הטיפול בנזעי חשמל. Decisions regarding the technique of ECT. Harefuah 1995; 129: 206-211.

3. Levkovitz Y, Weiser M, Levy A, Neuman M. אשפוז כפוי של חולי-חוץ: היבטים חוקיים ומוסריים. Involuntary outpatient commitment: ethical and legal aspects. Harefuah 1993; 124: 669-672.

4. Nechmad A, Fennig S, Ternochiano P, Treves I, Fennig-Naisberg S, Levkovitz Y. Siblings of schizophrenic patients. Isr J Psychiatry Relat Sci 2000; 37: 3-11.

5. Jeczmien P, Levkovitz Y, Weizman A, Carmel Z. Post-psychotic depression in schizophrenia. Isr Med Assoc J 2001; 3: 589-592. 6. Harel EV, Levkovitz Y. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review.

22 Levkovitz Yechiel, MD

Isr J Psychiatry Relat Sci 2008; 2:121-8.

7. Harel EV, Levkovitz Y. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review. Medical 2009; 12:28-32.

8. Schlaepfer TE, George MS, Mayberg H, Padberg F, Andrade C, Conca A, da Costa D, Eschweiler G, Fink M, Fitzgerald P, Gabriels L, Geretsegger C, Greenberg B, Holtzheimer P, Jasulaitis M, Krystal A, Levkovitz Y, Lijtenstein D, Lisanby SH, Mitchell P, Motohashi N, Naderi-Heiden A, Otegui J, Sackeim H, Tsukarzi E, Zervas I. WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry. World J Biol Psychiatry. 2009, 26:1-17.

9. D'Agati D, Bloch Y, Levkovitz Y, Reti I. rTMS for adolescents: Safety and efficacy considerations. Psychiatry Res 2010 30;177(3):280-5

10. Levkovitz Y, Tedeschini E, Papakostas GI Efficacy of antidepressants for Dysthymia: a meta analysis of placebo- controlled randomized trials. J. Clinical. Psychiatry 2011, 72:509-14.

11. Iovieno N, Tedeschini E, Levkovitz Y. , Amerall V, Papakostas GI. Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials. International Journal of Neuropsychopharmachology 2011, 4:1-8.

12. Gruberger M, Ben Simon E, Levkovitz Y. , Zangen A, Hendler T. Towards a neuroscience of mind-wandering Frontiers in Human Neuroscience 2011;5:56.

13 Shefet D, Levkovitz Y. A national educational interactive conference for psychiatry residents in Israel. Acad Psychiatry. 2011;35:419-20

14. Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1660-8

C. CHAPTERS IN BOOKS

1. Grisaru N, Belmaker RH, Einat H, Levkovitz Y, Segal M. TMS effects on animal models of depression and mania and hippocampal electrophysiology. TMS Book Chapter (2000). 23 Levkovitz Yechiel, MD

2. Segal-Trivitz Y, Bloch Y, Goldburt Y, Sobol-Havia D, Levkovitch Y, Ratzoni G. Borderline personality disorder. In Joav Merrick, Gil Zalsman (eds). Suicidal Behavior in Adolescence. Freund Publishing House Ltd., London and Tel Aviv, 2005.

24 Levkovitz Yechiel, MD

D.1 ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS

1992 Fifth international congress on Rehabilitation in Psychiatry, Jerusalem, Israel (invited lecture)

1993 Seventh conference of the South- East Europeane society for Neurology and Psychiatry, Jerusalem, Israel. (invited lecture)

1994 Weizman Institute of Science, Rehovot, Isreal. (invited lecture)

1994 Eight National Conference of the Israel Psychiatry Assiciation , May , Israel. (lecture)

1996 Eight National Conference of the Israel Biological Psychiatry Association , Israel. (Chair of symposia and lecture)

1996 Eight National Conference of the Israel Biological Psychiatry Associatio , Israel. (lecture)

1996 Society for Neuroscience, Israel. (lecture)

1997 American Society for Neuroscience. USA. (lecture)

1998 American Society for Neuroscience. USA. (lecture)

1999 American Society for Neuroscience. USA. (lecture)

1999 American College of Neuropsychopharmachology , Mexico. (lecture)

2003 8th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel. (invited lecture)

2005 9th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel. (invited lecture)

2006 10th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel. (invited lecture)

2006 The World Conference of Biological Psychiatry, Vienna, Austria. ( lecture)

2007 11th Conference of the Israel Society for Biological Psychiatry, Israel. (invited lecture)

2006 10th Conference of the Israel Psychiatry Association (organizing committee and lecture)

2006 Society of Biological Psychiatry, Toronto, Canada. (lecture)

2007 Society of Biological Psychiatry, San Diego, U.S.A. (lecture)

25 Levkovitz Yechiel, MD

2007 Johns Hopkins University, U.S.A. (invited lecture)

2008 Bar-Illan, Israel (invited lecture)

2008 Berlin , Congress International Neuropsychopharmachology (CINP) (invited lecture)

2009 The 64th annual conference of the American society of Biological Psychiatry (SOBP). USA (lecture)

2009 The 13th conference of the Israel Society of Psychiatry, Israel. .(invited lecture) 2009 The 13th conference of the Israel Society of Psychiatry, Israel. .(invited lecture) 2009 Paris , 9th World Congress of Biological Psychiatry.(chair of symposia and invited lecture) 2010 McLean, Harvard School of Medicine. .(invited lecture) 2010 Beth Israel, Harvard School of Medicine. .(invited lecture) 2010 Grand Round, Psychiatry Department, Tauft, Harvard School of Medicine. .(invited lecture) 2010 Massachusetts General Hospital, Harvard School of Medicine. .(invited lecture) 2010 France Association for Biological Psychiatry and Neuropsychopharmachology, Lyon, France.(invited lecture) 2011 10th world congress of biological psychiatry. Prague , Czech (invited lecture) 2011 CINP, Hong Kong, (invited lecture) 2012 Brazilian Association of Psychiatry, Natal Brazil (two invited lecture) 2012 Shaar-Menash Psychiatry Hospital, Israel (invited lecture) 2012 Beer-Yakov Psychiatry Hospital, Israel (ilecture) 2012 Lev-Hasaron Psychiatry Hospital, Israel (invited lecture) 2012 Tirat- Hacarmel Psychiatry Hospital, Israel (invited lecture) 2012 Ramat-Hen Mental Health Center, Israel (invited lecture) 2012 Israel Association of Psychiatry, Israel (3 invited lecture)

D.2.. PAPERS PRESENTED AT SCIENTIFIC MEETINGS

1. A.M. Olman, I, Abramovitch. Y. Levkovitz, R. Barkai, I. Levin, M. Neuman. Psychiatric hospitalization as a risk factor for Hepatitis B infection. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

26 Levkovitz Yechiel, MD

2. M. Weiser, Y.Levkovitz, M.Neuman, S.Yehuda. Decrease in serum iron in acutely psychotic schizophrenic patients Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

3. S. Stropinski, Y. Levkovitz, Y. Abraovitch, I. Nitzan. Body Dysmorphic Syndrom : Case reporte and disscusion. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

4. M. Polak, Y.Levkovitz, I. Levin, A. Levy, A. Ben-Arzi, Y. Makori, M.Neuman. Intracelluar calcium ion concentration in lymphocyte before and after activation by PHA (Phytohemagglutinine) in depressed and manic patients. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

5. Y. Kronnenberg, Y. Levkovitz, Y. Rosenstreic ,Y. Tamir, N. Keisar, B.Gaoni. Telephone as trantisional object in psychodynamic thrapy. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

6. Y. Kronnenberg, Y. Levkovitz, Y. Rosenstreic ,Y. Tamir, N. Keisar, B.Gaoni. The relationshipe anorexia, incest and psychosis. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

7. M. Slavine, Y. Levkovitz, Y. Kronnenberg, B.Gaoni. The diagnosis of acute psychosis after trauna in hospitalized adolescens. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

8. Y. Levkovitz, Y. Kronnenberg, N. Keisar, B.Gaoni. Clozapine for Tardive Dyskinesia in adolescences. Eight National Conference of the Israel Psychiatry Assiciation , May 1994, Israel.

9. Y. Levkovitz, M.segal. The interaction between cholinergic and serotonergic neuronal systems in the hippocampal rat. the 2nd international conference on new directions in affective disorders, September, 1995, Israel.

10. Y.Bloch, Y.Levkovitz, I.Treves, M.Neuman. The effect of activating the cholinergic, the serotonergic or both systems on the cognitive side effects caused by ECT. the 2nd international conference on new directions in affective disorders, September, 1995, Israel.

27 Levkovitz Yechiel, MD

11. Y. Levkovitz, A.Bloch, I.Treves , M.Neuman The effects of interaction between the cholinergic and serotonergic systems on the cognitive impairment in depression and ect. European Neuropsychopharmachology, Vol 6, pp. 15, (Suppl), 1996, Israel.

12. H.Harari, Y.Levkovitz, I.Treves, M.Neuman. The effect of new serotonin type 3 and 4 agonist and antagonist on memory impairment induced by electroconvulsion shock in rats. The 2nd international conference on new directions in affective disorders, September, 1995, Israel.

13. Y.Bloch,M.Polliack, Y.Levkovitz, I.Treves, M.Neuman The effect of flumazenil-a benzodiazepine antagonist on the electricl thershold and cognitive side effects caused by electroconvulsion thrapy. The 2nd international conference on new directions in affective disorders, September, 1995, Israel.

14. Y. Levkovitz, M.Segal Acetylcholine mediates the effects of serotoninon hippocampal cell excitability in the rat. Israel Society for Neuroscience, December, 1995, Israel. Israel Journal of Medical Sciences, Vol. 31, pp. 723, 1995.

15. Y. Levkovitz, A.Bloch, I.Treves , M.Neuman The effects of interaction between the cholinergic and serotonergic systems on the cognitive impairment in depression and ect. European Neuropsychopharmachology, Vol 6, pp. 15, (Suppl), 1996, Israel.

16. Y. Levkovitz, M.Segal. . Serotonin 5-HT- 1A receptors modulate hippocampal reactivity to afferent stimulation. American Society for Neuroscience. 1997, USA.

17. Y. Levkovitz, J. Marx, N. Grisaru, M. Segal. Long term effects of Transcranial Magnetic Stimulation on hippocampal reactivity to afferent stimulation. American Society for Neuroscience. 1998. USA.

18. Y. Levkovitz, M.Segal. Aging affects Transcranial Magnetic Modulation of hippocampal evoked potentials. American Society for Neuroscience. 1999. USA.

19. Y. Levkovitz, N. Grisaru, M. Segal. Transcranial Magnetic Stimulation and antidepressant drugs affect similar cellular mechanisms in the rat hippocampus. American College of Neuropsychopharmachology 1999. USA.

20. Levkovitz Y, O`Donovan KJ, Baraban JM. Blockade of NGF-induced Neurite Outgrowth by a Dominant Negative Inhibitor of the Egr Family of Transcription Regulatory Factors. American Society for Neuroscience. 2000. USA.

21. Levkovitz Y, Baraban JM. 28 Levkovitz Yechiel, MD

A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. 8th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel. 2003

22. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A . Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase- 3 involvement. 9th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel. 2005

23. Levkovitz Y, Ben-Shushan G, Gil-Ad I, Shvartsman D, Ronen D, Weizman A, Zick Y. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. 10th Conference of the Israel Society for Biological Psychiatry, Hagoshrim, Israel 2006

24. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation - a physical and psychological study clinical neurophysiology. The World Conference of Biological Psychiatry, Vienna, Austria. 2006

25. Levkovitz Y, Harel E, Roth Y, Zangen A. Deep transcranial magnetic stimulation in major depression: from animal models to clinical application. 11th Conference of the Israel Society for Biological Psychiatry, Kfar Giladi, Israel. 2007.

26. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation - a physical and psychological study clinical neurophysiology. 10th Conference of the Israel Psychiatry Association ("Novel Diagnostic and Treatment Tools in Psychiatry" 2006

27. Levkovitz Y, Shamay-Tsoory SG. Dissociation of cognitive from affective components of theory of mind in schizophrenia. Society of Biological Psychiatry, Toronto, Canada. 2006

28. Levkovitz Y. Transcranial magnetic stimulation in major depression: from animal models to clinical application. Symposia: Novel Strategy and Tool in the Field of TMS, Society of Biological Psychiatry, San Diego, U.S.A. 2007

29 Levkovitz Yechiel, MD

29. Levkovitz Y. Zangen A. The role of TMS in modern psychiatry. Invited Speaker, Research Seminar, Psychiatry Department, Johns Hopkins University, U.S.A. 2007

29. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation - a physical and psychological study clinical neurophysiology. The Batsheva de Rothschild Interdisciplinary Workshop on Transcranial Magnetic Stimulation (TMS) .Israel. 2008

30. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation in depression from basic science to clinical application. Invited Speaker , Berlin , Congress International Neuropsychopharmachology (CINP) 2008.

31. Levkovitz Y . Minocycline in early phase schizophrenia: from the lab to the clinic. Vancouver. The 64th annual conference of the American society of Biological Psychiatry (SOBP). 2008.Canada

32. Levkovitz Y. Neuromodulation in psychiatry. The 13th conference of the Israel Society of Psychiatry, Israel. 2008. 33. Levkovitz Y. Education and expertise in psychiatry. The 13th conference of the Israel Society of Psychiatry, Israel. 2009. 34. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation for depression Chair of Symposia and speaker., Paris , 9th World Congress of Biological Psychiatry. 2009

35. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation for affective disorder Invited Speaker, Psychiatry Department, McLean, Harvard School of Medicine. 2009 36. Levkovitz Y. Zangen A. Deep transcranial magnetic stimulation for affective disorder Invited Speaker, Neurology and Cognitive Neurology Department Beth Israel, Harvard School of Medicine. .2010 37. Levkovitz Y. Deep transcranial magnetic stimulation for affective disorder Invited Speaker, Grand Round, Psychiatry Department, Tauft, Harvard School of Medicine. 2010 39. Levkovitz Y. 30 Levkovitz Yechiel, MD

Deep transcranial magnetic stimulation for affective disorder Invited Speaker, France Association for Biological Psychiatry and Neuropsychopharmachology, Lyon, France. 2010 40. Levkovitz Y. Latest update of deep transcranial magnetic stimulation. 10th world congress of biological psychiatry. Prague , Czech 2011